An FDA panel spread misinformation about SSRI use in pregnancy, alarming doctors

Doctors are criticizing a caller master sheet organized by nan U.S. Food and Drug Administration that questioned nan information of taking antidepressants during pregnancy. Mykola Sosiukin/Getty Images hide caption

toggle caption

Mykola Sosiukin/Getty Images

Nearly 1 successful 5 pregnant women and caller moms successful this state suffers from worry and depression. And 6-8% of pregnant women are prescribed a group of antidepressants called Selective Serotonin Reuptake Inhibitors (SSRIs).

But a caller master sheet organized by nan U.S. Food and Drug Administration formed uncertainty connected nan information of SSRIs — moreover though these narcotics are mostly considered safe by healthcare providers.

Those comments person sparked a swath of disapproval from a number of salient aesculapian societies.

"Untreated aliases undertreated slump during gestation carries wellness risks, specified arsenic suicide, preterm birth, preeclampsia, and debased commencement weight," the Society for Maternal-Fetal Medicine wrote successful a connection precocious past month. "Unfortunately, misinformation astir slump and its curen creates disorder and uncertainty among patients and nan nationalist starring to unnecessary barriers to care."

Opening nan sheet chat connected FDA connected July 21, FDA Commissioner Marty Makary said that SSRIs person been "implicated" by studies to beryllium progressive successful a scope of wellness effects, including pulmonary hypertension and cardiac defects successful babies. Then a mostly of nan panelists, including psychiatrists, psychologists and a societal activity professor, cited studies they said exemplify superior wellness risks, for illustration miscarriage and autism.

Several groups of healthcare providers, including nan American College of Obstetricians and Gynecologists (ACOG) and nan National Curriculum for Reproductive Psychiatry person spoken retired against galore of nan claims made by nan panel, saying that it misrepresented grounds and dispersed misinformation.

"As experts successful high-risk pregnancies, nan Society for Maternal-Fetal Medicine (SMFM) and its members are alarmed by nan unsubstantiated and inaccurate claims made by FDA panelists concerning maternal slump and nan usage of SSRI antidepressants during pregnancy," according to the connection from SMFM.

"Robust evidence" illustrates nan information of SSRI usage successful pregnancy, according to nan ACOG statement, which added that astir of these medications "do not summation nan consequence of commencement defects."

Responding to that criticism, spokesperson for nan Department of Health and Human Services, Andrew Nixon wrote this to NPR successful an email: "The declare that nan FDA's master advisory process is one-sided aliases politically driven is insulting to nan independent scientists, clinicians, and researchers."

Scientific 'apples and oranges' 

Some of nan studies cited by nan panelists arsenic grounds of harm didn't moreover impact pregnant and postpartum women, says Dr. Jennifer Payne, a reproductive psychiatrist astatine nan University of Virginia and a past president of nan Marcé of North America, an statement moving to forestall and dainty intelligence wellness conditions during and aft pregnancy.

For example, British psychiatrist Dr. Joanna Moncrieff referenced a study successful younker linking SSRIs to accrued suicidality successful a "very mini proportionality of" those taking nan medication, she said.

Many of nan studies referenced by immoderate panelists person been disproven, notes Payne, for illustration nan papers linking SSRI usage successful gestation to cardiac defects successful infants. "That has been debunked complete and over," she says.

And respective studies mentioned connected nan sheet were "poorly controlled," says Payne.

"So if you're comparing a pregnant diligent who was taking an SSRI, nan power group should beryllium nan pregnant diligent pinch intelligence wellness abnormalities who hasn't taken an SSRI," explains Dr. Christopher Zahn, main of Clinical believe pinch nan American College of Obstetricians and Gynecologists aliases ACOG, who wasn't portion of nan panel. "And portion of nan problem pinch a number of those studies [cited by panelists] is they don't usage nan correct power group. It's really apples and oranges."

And studies that are well-controlled — successful different words, those that comparison pregnant women connected SSRIs pinch pregnant women pinch intelligence wellness conditions not taking nan narcotics — do not find nan risks highlighted by nan FDA panel.

"The usage of SSRIs successful gestation is highly good studied," says Dr. Nancy Byatt, a perinatal psychiatrist astatine nan UMass Chan School of Medicine. "We person information connected hundreds and thousands of individuals exposed to SSRIs successful pregnancy."

That information show that by and large, SSRIs are safe. "What nan wide information shows is that antidepressants are not associated pinch awesome commencement defects," says Byatt.

Some studies person recovered a consequence of postpartum hemorrhage from SSRIs, but nan consequence is mini and "does not outweigh nan consequence of maternal psychiatric illness," says Payne. And researchers haven't ruled retired nan anticipation that different factors successful women pinch intelligence illnesses for illustration hypertension and obesity whitethorn beryllium contributing to nan wide consequence of hemorrhage aft delivery, she adds.

For miscarriage, while immoderate studies person recovered SSRI usage successful gestation to beryllium linked to a higher risk, astir of those studies don't power for different consequence factors for illustration slump itself, which is besides associated pinch miscarriage risk.

The impacts of untreated perinatal depression 

One rumor that was not discussed capable by nan panel, according to Byatt and different experts connected perinatal intelligence health, is nan well-documented wellness impacts of untreated intelligence wellness symptoms successful pregnant and postpartum women. Only 1 panelist, Dr. Kay Roussos-Ross, OBGYN and perinatal psychiatrist astatine nan University of Florida, spelled retired those impacts.

"When intelligence wellness conditions spell untreated, these women are little apt to be their prenatal attraction appointments and they're much apt to usage substances during their pregnancy," said Roussos-Ross. "They are besides much apt to look further risks, specified arsenic pre-eclampsia and cesarean delivery." They're besides astatine a higher consequence of suicide, she said. Mental wellness remains nan starring origin of maternal deaths in nan United States, including deaths from suicide.

"And there's this immense lit connected nan effects of postpartum depression, connected IQ, connection development, behavioral problems" successful children, says Payne. "It's arsenic clear arsenic a doorbell that you want mom to beryllium well, during gestation and postpartum."

However, SSRIs aren't nan only curen action for pregnant and postpartum women, opportunity Payne and others.

"We person a batch of devices successful our toolbox," says Byatt.

For mild slump aliases anxiety, nan first statement of curen is psychotherapy, aliases talk therapy, she says. "We person evidence-based psychotherapies that we can, should and do usage successful gestation and postpartum."

There's besides psychosocial treatments, for illustration adjacent support, which tin beryllium very adjuvant successful improving pregnant women's and caller moms' symptoms.

Adding practices for illustration exercise, yoga and meditation to those treatments is besides thing Byatt recommends to her patients.

"Often group can't entree therapy quickly because of deficiency of security aliases moreover if group do person insurance, it's extraordinarily challenging for group to entree evidence-based value therapy," notes Byatt.

So for those women, and ones pinch mean to terrible symptoms, she says, SSRIs are a adjuvant option.